RINASCERA THERAPEUTICS, INC.

Profile

Company Names

RINASCERA THERAPEUTICS, INC.

Addresses

75 KNEELAND ST FL 14, BOSTON, MA 02111

Phone Numbers

(408) 396-3123

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2025

State Incorporated:

DELAWARE

Total Amount Raised:

$2,500,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-09-12 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KARL 
 
BEUTNER 
EXECUTIVE OFFICER, DIRECTOR
RINASCERA THERAPEUTICS, INC.
MAX 
 
DAWSON 
EXECUTIVE OFFICER
DERMBIONT, INC.   |  RINASCERA THERAPEUTICS, INC.
NICHOLA 
 
ELIOVITS 
EXECUTIVE OFFICER, DIRECTOR
SCRIPTDASH INC.   |  DERMBIONT, INC.   |  ALTO PHARMACY HOLDINGS, INC.   |  MENDEL HEALTH INC.   |  OT DST FUND I, LLC   |  OT PHARMA FUND VIII, LLC   |  OT MATERIALS FUND I, LLC   |  MAVERICK BIOMETALS INC.   |  OT HEALTHCARE FUND I, LLC   |  OT YC FUND IV, LLC   |  PHOENIX TAILINGS, INC.   |  OT PHARMA FUND IX, LLC   |  OT MATERIALS FUND II, LLC   |  RINASCERA THERAPEUTICS, INC.   |  OT AI INFRASTRUCTURE FUND I, LLC   |  OT QUANTUM FUND I, LLC   |  MAVERICK LABS, INC.   |  OT HEALTHCARE FUND III, LLC   |  OT ROBOTICS FUND I, LLC   |  OT AI CYBER FUND I, LLC
DANIEL 
 
YADEGAR 
DIRECTOR
NEWPATH PARTNERS, L.P.   |  DERMBIONT, INC.   |  RINASCERA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-09-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#